On April 10, the China Securities Regulatory Commission approved the IPO of 5 companies and agreed to register 2 companies on the science and technology board. Since the beginning of the year, a total of 44 companies have approved IPOs, and 23 companies have agreed to register on the science and technology board; 57 companies have completed the issuance and raised 82.377 billion yuan in financing. On average, three companies are approved for IPO every week, and two companies are approved to register on the science and technology board.
On April 10th, intensive approvals were issued, triggering market speculation about whether the IPO review will be accelerated.
According to the above speculations, the Securities Times reporter learned from the authoritative person on the evening of April 12th that in the prevention and control of epidemic situation, resumption of production and other work, it is better Give play to the role of capital market hub. On the basis of maintaining the basic stable operation of the market, we will continue to adhere to the normalized issuance of new shares, coordinating the progress of the review according to the status of the declared enterprise, and issuing a certain number of IPO approvals every week. It neither suspends the IPO issuance due to various factors nor reduces the quality of checkpoints due to various factors, helps enterprises solve the more urgent shortage of funds, promotes the in-depth integration of technological innovation and economic development, and gives full play to the capital market to serve the real economic development and service maintenance The role of the overall situation of stable economic development. At the same time, according to market conditions, maintain a stable issuance rhythm, appropriately increase support for corporate financing, but do not engage in the Great Leap Forward-style centralized approval approval, continue to clarify market expectations and maintain market stability.
(Originally titled “Authorities: Do not engage in the Great Leap Forward-style centralized approval of IPO approval”)